BmLAO-f2

General Information


DRACP ID  DRACP03473

Peptide Name   BmLAO-f2

Sequence  KKFWEDDG

Sequence Length  8

UniProt ID  B3EWI9 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03473

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C47H65N11O15

Absent amino acids  ACHILMNPQRSTVY

Common amino acids  DK

Mass  114914

Pl  4.37

Basic residues  2

Acidic residues  3

Hydrophobic residues  2

Net charge  -1

Boman Index  -2910

Hydrophobicity  -210

Aliphatic Index  0

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  785.71

Polar residues  1

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22438972

Title  Evaluation of an antimicrobial L-amino acid oxidase and peptide derivatives from Bothropoides mattogrosensis pitviper venom

Doi Not available

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  4694

DRACP is developed by Dr.Zheng's team.